✦ LIBER ✦

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

✍ Scribed by Volker Heinemann; Stefan Boeck; Axel Hinke; Roberto Labianca; Christophe Louvet

Book ID: 115011499
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 313 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-82

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine in the treatment of advanced

Gemcitabine in the treatment of advanced pancreatic cancer: A comparative analysis of randomized trials

✍ Volker Heinemann 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Survival benefit of chemotherapy in meta

Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials

✍ Jonker, D J; Maroun, J A; Kocha, W 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

A Randomized Phase 2 Trial of Neoadjuvan

A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin

✍ Daniel H. Palmer; Deborah D. Stocken; Helen Hewitt; Catherine E. Markham; A. Bas 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 226 KB

A meta-analysis of randomized controlled

A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer

✍ Jiang, Jingwei; Liang, Xiaohua; Zhou, Xinli; Huang, Ruofan; Chu, Zhaohui 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Should chemotherapy combinations for adv

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials

✍ Pujol, Jean-Louis; Barlesi, Fabrice; Daurès, Jean-Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Gemcitabine-based combinations for inope

Gemcitabine-based combinations for inoperable pancreatic cancer: Have we made real progress? : A meta-analysis of 20 phase 3 trials

✍ Emilio Bria; Michele Milella; Alain Gelibter; Federica Cuppone; Maria Simona Pin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract ## BACKGROUND. Several attempts have been made at improving the efficacy of gemcitabine in advanced pancreatic cancer by combining it with other chemotherapeutic or molecularly targeted agents. However, randomized trials have produced conflicting results. ## METHODS. All prospective,